IL38268A - Reduction of thebaine to 8,14-dihydrothebaine - Google Patents

Reduction of thebaine to 8,14-dihydrothebaine

Info

Publication number
IL38268A
IL38268A IL38268A IL3826871A IL38268A IL 38268 A IL38268 A IL 38268A IL 38268 A IL38268 A IL 38268A IL 3826871 A IL3826871 A IL 3826871A IL 38268 A IL38268 A IL 38268A
Authority
IL
Israel
Prior art keywords
thebaine
sulphonic acid
base
dihydrothebaine
substituted
Prior art date
Application number
IL38268A
Other languages
Hebrew (he)
Other versions
IL38268A0 (en
Original Assignee
Macfarlan Smith Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Macfarlan Smith Ltd filed Critical Macfarlan Smith Ltd
Publication of IL38268A0 publication Critical patent/IL38268A0/en
Publication of IL38268A publication Critical patent/IL38268A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

38268/2 Reduction of aobaiae 8,14-dihydrothe¾aiae, This invention relates to an improved process for the reduction of thebaine to 8714-dihydrothebaine, and to the 8jl¾-dihydrothebaine so produced. 8;fl¾-dihydrothebaine is an intermediate in the production of dihydrocodeinone, also known as hydrocodone, which is a well known analgesic compound produced by hydrolysis of 8J14-dihydrothebaine. The production of 8 14-dihydrothebaine by known methods as described below presents certain difficulties and it is the object of the present invention to overcome or lessen these difficulties and to provide an improved process for the production of 8^1 -dihydrothebaine thereby facilitating production of dihydrocodeinone. It is also an object of the invention to make the utilisation of thebaine obtained as by-product in the extraction of morphine from opium more economically attractive.
The classical known method for the reduction of thebaine to is catalytic hydrogenation. Owing to extensive side reactions (such as hydrogenolysis of the ether bridge, and the formation of significant amounts of tetrahydrothebaine by Ir i type of addition of hydrogen to the conjugated double bond system), however, the yield of 8^1¾-dihydrothebaine obtained is only 50 -60# of theory. A further disadvantage of this process is that it requires a relatively pure grade of thebaine as starting material if poisoning of the hydrogenation catalyst is to be avoided.
It is known that hydrazine and certain of its derivatives are highly selective reducing agents for carbon - carbon or nitrogen - nitrogen double bonds, and a number of such reductions have been described. When hydrazine is employed, an oxidising agent such as air or oxygen is necessary to bring about the reduction of the double bond since the true reducing agent is not hydrazine itself, but an unstable intermediate diimine NH = NH formed by oxidation of the hydrazine, thus : 2NH2.NH2 + 02 »2NH = NH + 2H20 The application of this procedure to the reduction of thebaine to 8-j"l¾-dihydrothebaine has recently been described by Rapoport jel al (Helv. Chim. Acta, ( 2 ) , 393, 1968 ; ) .
This process involved the use of gaseous oxygen, which is hazardous on an industrial scale since mixtures of hydrazine vapour and oxygen are potentially explosive, and employed a molar ratio of hydrazine to thebaine of 53 ! 1 which^LS commercially unattractive.
The production of diimine by methods other than the oxidation of hydrazine has been described. One such method is the thermal decomposition of the hydrazides of aryl sulphonic acids such as benzenesulphonic acids, as follows : SOgNH.NHg h6at> S02H + NHlNH The primary products of this decomposition are the aryl sulphinic acid and diimine, although in the absence of a base the benzene sulphinic acid may undergo further reaction to form sulphur compounds such as S-phenyl benzenethiosulphonate and diphenyl sulphide which can lead to a reduced yield of diimine. If, however, a base such as ethanolamine is present reaction of the benzene sulphinic acid can be prevented and the formation of these sulphur compounds largely avoided. It should be noted that this method of forming diimine does not require the use of either free hydrazine or oxygen and thus eliminates the hazard associated with the Rapoport procedure. More efficient utilization of the hydrazine in the reductio of carbon - carbon double bonds can also be achieved by using benzene sulphonyl hydrazide as the source of diimine rather than hydrazine/oxygen.
A further method of producing diimine is by the thermal decomposition of disodium azodicarboxylate in the presence of a protic substance. Substituted acyl hydrazides for example, chloracetyl hydrazide, can also be used to produce diimine.
According to the present invention there is provided a process for the preparation of 8J14-dihydro-thebaine from thebaine, in which the thebaine is reduced by heating it with at least one of the thermally decomposabl compounds selected from an aryl sulphonic acid hydrazide, an alkyl sulphonic acid hydrazide, an aralkyl sulphonic provided that when disodium azodicarboxylate acid hydrazide or disodium azodicarboxylate/is used, a proton supplying substance is present.
The process according to the invention leads to improved overall yields of dihydrocodeinone prepared from the 8^14-dihydrothebaine produced compared with those yields obtained when the first stage is the catalytic hydrogenation process or the Rapoport procedure using hydrazine and oxygen mentioned above. It also obviates the explosion hazard associated with the use of free hydrazine and free oxygen. It is also applicable to a technical grade of thebaine which is not of sufficient purity for use in the catalytic hydrogenation process because of the fact that it causes the hydrogenation catalyst to become rapidly poisoned. In addition, when using the hydrazine in its combined form as a sulphonyl hydrazide, it is utilized more efficiently than when employed as free hydrazine. Thus satisfactory reduction of thebaine has been obtained with 2 : 1 molar ratio of hydrazide to thebaine. Indeed according to the invention no particular purpose is served by increasing this molar ratio to over 4 : 1.
In carryin out th process of the invention the aryl sulphonic acid may be one in which the aryl group is a benzene or6aphthalene radical or a substituted benzene or substituted naphthalene radical, e.g. a mono- or poly-alkyl substituted benzene radical. Preferred aryl sulphonic acids are benzene and p-toluene sulphonic acid.
The hydrazide of the aryl sulphonic acid may be used in the form of a commercially available solid as in Examples h and 7· I may also be prepared in the form of a solution by prior reaction of hydrazine and an aryl sulphonyl chloride as in Example 2. It may also be prepared in situ - as in Example 3.
An example of an alkyl sulphonic acid hydrazide which may be used is methane sulphonic acid hydrazide, but others having branched or unbranched alkyl groups may also be used. Furthermore the alkyl groups may be substituted or unsubstituted. An example of an aralkyl sulphonic acid hydrazide which may be used is benzene, sulphonic acid hydrazide, but others in which the aromatic group or the alkyl group or both are substituted may also be employed. The hydrazide may be in the form of a solid, a slurry or solution which is added to the reaction mixture or may be formed in situ.
Diimine can also be produced by the thermal decomposition of disodium azodicarboxylate in the presence of a proton supplying substance. Any substance which is capable of supplying protons may be used, for example, acids, alcohols, water. Disodium azocarboxylate may be prepared from azodicarbonamide, (commercially available as Genitron AC, which is a trade mark) by treatment with cold aqueous concentrated sodium hydroxide solution as described in Annalen der Chemie, 271, 130 (1892).
When a sulphonic acid hydrazide is employed the reaction according to the invention is preferably carried out in the presence of a base, either organic or inorganic although this is not essential. If an organic base is used it should have a boiling point above that at which the diimine-producing compounds decompose. A practical lower limit in this respect is a boiling point of at least 80°C. Suitable bases which may be used include alkali metal hydroxides, ammonia, alkylamines, substituted alkylamines, aralkylamines, substituted aralkylamines and heterocyclic bases. Specific examples of such bases include sodium hydroxide solution, ethanolamine, morpholine, benzylamine and ethylene diamine.
The reaction is also preferably carried out in the presence of a solvent. Suitable solvents are in general those which are inert to thetaaine and to the reaction product. They should also have a boiling point at which the diimine-produeing compound decomposes with reasonable speed. In practice a boiling point of 80°C or over is preferred. Examples of solvents which may be used are methyl oxitol, diglyme, amyl alcohol, diethyl carbonate and morpholine. It is especially preferred to use morpholine when the source of diimine is a sulphonylhydrazide. This is because morpholine acts as both a base and solvent and gives exceptionally good results in the process of the invention.
The molar ratio of the reactants required is determined by the necessity to employ sufficient diimine-producing compound to achieve as near total reduction or the 8 14 double bond of thebaine as practical. This can generally be achieved in accordance with the invention by using a molar ratio of diimine-produeing compound to thebaine of not greater than 4:1, and usually a ratio of 2:1 suffices.
The 8 {l4-dihydrothebaine prepared by the process of the invention can be hydrolysed to dihydrocodeinone, for example by the procedure described in Example 1 and the invention includes such hydrolysis and dihydrocodeinone so produced.
The following Examples illustrate the invention: EXAMPLE 1 62 g of technical thebaine alkaloid was refluxed with 150 ml of methyl oxitol (2-methoxyethanol) and 20 ml of ethanolamine. 74 g of p-toluene sulphonyl hydrazide dissolved in 150 ml methyl oxitol was added to the refluxing solution over 15 minuses. The mixture was then refluxed for a further 1 hour. The solvent was removed by distillation under reduped pressure and water was added to the residue followed by caustic soda solution, with stirring, until the mixture was alkaline to Clayton yellow indicator paper. After cooling the crude 8^1¾-dihydrothebaine was filtered off, washed and dried. Yield 58 g (93$ theory on thebaine), m.p. 162° - l6¾°C. The product was over 99$ pure by GLC analysis.
Hydrolysis to dihydrocodeinone The 8;l¾-dihydrothebaine (58 g) was boiled under reflux with excess 2N aqueous hydrochloric acid solution for 30 minutes. After cooling, the reaction solution was run into excess 20 aqueous sodium hydroxide solution containing 10$ I.M.S. (66 o.p.) with stirring. The precipitated dihydrocodeinone base was filtered, washed free of caustic soda with water and dried at 60°. Yield 53 g (88$ of theory on thebaine). m.p. 196-8°.
In order to illustrate the effect of different solvents on the process of the invention, Example 1 was repeated using different solvents. The results are shown in Table I.
T A B L E I Solubility of p-toluene Solvent sulphonylhydrazide Amyl Alcohol insoluble Dimethyl formamide soluble Perchloroethylene insoluble Xylene insoluble I Amyl acetate insoluble I Chlorobenzene insoluble Diglyme soluble Dimethyl sulphoxide soluble Diethyl carbonate insoluble Ethanolamine soluble Pyridine soluble Morpholine soluble In all the above cases ethanolamine vas used as the added base, except for those solvents which are themselves bases and where the use of an additional base was considered unnecessary. It will be seen that the only solvents other than methyl oxitol which gave a significantly better yield of dihydrocodeinone were diethyl carbonate and morpholine. The p-toluene sulphonylhydrazide was not completely soluble in the diethyl carbonate and therefore had to be added in the form of a slurry with the solvent, which is a disadvantage although not a serious one. The hydrazide was, however, completely soluble in the morpholine and this solvent gave the best yield of dihydrocodeinone of all those tested.
Similarly, the effect of different bases on the process of the invention was shown by repeating Example 1 using a variety of bases. The results are shown in Table 2.
T_A_B_L_E__2 Base Yield of dihydro- codeinone on thebaine None 62.2 Sodium hydroxide (50$ w/w aqueous solution) 88.7 Triethanolamine 80.3 Aniline 65.8 Dimethylaniline 61.8 Pyridine 6 .7 Morpholine 87.5 Ethylene diamine 89 None of the above bases gave significantly better results than ethanolamine, but it is interesting to note that the inorganic base sodium hydroxide gave results equal to those obtained with ethanolamine and other organic bases. Although the reaction proceeds in the complete absence of a base, the yield of dihydrocodeinone obtained is substantially reduced. Weak bases such as aniline, dimethylaniline and pyridine give a similar result to that obtained when no base at all is present.
EXAMPLE 2 40 g of p-toluene sulphonyl chloride was suspended in 75 ml of methyl oxitol and cooled in an ice bath. 12 ml of ethanolamine and 12 ml of hydrazine hydrate (98$) were added slowly keeping the temperature below 20°C. After the reaction was complete the mixture was warmed to dissolve all the solid present and the solution added slowly to a refluxing solution of 31 g of technical thebaine and 10 ml of ethanolamine in 75 ml of methyl oxitol. The reaction mixture was worked up by the procedure described in Example 1 and yielded 27.6 g (89$ theory) of crude 8^1 -dihydro-thebaine, m.p. l62-l66°C.
EXAMPLE 3 31 g of technical thebaine, 30 ml of ethanolamine, 75 ml of hydrazine hydrate (98$) and 75 ml of methyl oxitol were brought to reflux temperature in a nitrogen atmosphere. O g of p-toluene sulphonylchloride dissolved in 75 ml of methyl oxitol was then added to the refluxing solution over 15 minutes. Work-up of the reaction mixture as described in Example 1 yielded 27 g of crude 8-jTA-dihydrothebaine, m.p. 162 - 166°C.
EXAMPLE k 31 g of technical thebaine, 10 ml of ethanolamine and 75 ml of methyl ox:-.tol were brought to reflux temperature and 35 g of benzene sulphonyl hydrazide (Trade Name Genitron BSIl) in 75 ml. of^iethyl oxitol added over the course of 15 minutes. Work-up of the reaction mixture as described in Example 1 yielded 28 g of crude 8^1 -dihydrothebaine, m.p. 162 - l6¾°C.
EXAMPLE 5 31 g of technical thebaine, 10 ml of ethanolamine and 75 mi of toluene were brought to reflux temperature. 37 g of p-toluene sulphonyl hydrazide dissolved in 75 ml of warm toluene were added as in Example 1. Work-up as in Example 1 gave 28 g of rather poor quality (m.p. 158° -174°C) crude 8jl4-dihydrothebaine.
EXAMPLE 6 31 g of technical thebaine, 10 ml of ethanolamine and 75 ml of diglyme (diethylene glycol dimethyl ether) were brought to reflux temperature and 37 g of p-toluene sulphonyl hydrazide dissolved in diglyme was added as described in Example 1. Work-up as in Example 1 yielded 28 g of crude 8jri4-dihydrothebaine, m.p. 162° - l6½°C.
EXAMPLE 7 Example 1 was repeated using a commercial grade of p-toluene sulphonyl hydrazide (Trade Name Unifor H) in place of pure material prepared by laboratory synthesis.
The results obtained were essentially the same. 8lA-dihydrothebaine prepared according to Examples 2 to 7 could be hydrolysed to dihydrocodeinone as described in Example 1.
EXAMPLE 8 300 ml of morpholine, .nd a solution of 1¾8 g of p-toluene sulphonylhydrazide in 300 ml of morpholine was added over the course of about 15 minutes while maintaining the reaction mixture at reflux temperature. After the addition of hydrazide was complete, the mixture was refluxed for a further period of 1 hour and the dihydrothebaine isolated as described in Example 1.
The whole of the dihydrothebaine thus obtained was hydrolysed with two normal hydrochloric acid as in Example 1 to yield 112 g (9 f> theory on thebaine) of dihydrocodeinone, m.p. 197°C.
EXAMPJJE 9 To a solution of 10 g of technical thebaine alkaloid and 10 ml of ethanolamine in 50 ml of boiling methyl oxitol was added two molar equivalents (referred to the thebaine) of methane sulphonylhydrazide dissolved in methyl oxitol over the course of about 0 minutes, while maintaining the reaction mixture at reflux temperature. When the addition was complete the mixture was refluxed for a further period of one hour and the dihydrothebaine isolated as in Example 1. The whole of the dihydrothebaine thus obtained was hydrolysed as in Example 1 to give 8.2 g ( 85 theory on thebaine) of good quality dihydrocodeinone.
EXAMPLE 10 31 g of technical thebaine in 150 ml of methyl oxitol was treated at reflux temperature with a slurry of O g of di sodium azodicarboxylate and 100 ml methyl oxitol added over the course of 30 minutes. When the addition was complete the reaction mixture was refluxed and stirred for a further period of 0 minutes, and the resulting dihydro- thebaine then isolated as described in Example 1. The whole of the dihydrothebaine thus obtained was hydrolysed as in Example 1 to give 21 g (70$ theory on thebaine) of dihydro-codeinone, in. . 195° - 197°C.

Claims (20)

HAVING NOW particularly described and ascertained the nature of our said invention and in what manner the same is to beC performed, we declare that what we claim is:
1. A process for the preparation of e^l^-dihydro-thebaine from thebaine, in xvhich the thebaine is reduced by heating it with at least one of the thermally decomposable compounds selected from an aryl, or substituted aryl sulphonic acid hydrazide, an alkyl or substituted alkyl sulphonic acid hydrazide, an aralkyl or substituted aralkyl sulphonic acid hydrazide or di sodium azodicarboxylate, provided that when disodium azodicarboxylate is used, a proton supplying substance is present. as claimed in claim 1
2. A process/for the preparation of e^l^-dihydro-thebaine from thebaine, in which the thebaine is reduced by heating it with an aryl sulphonic acid hydrazide decomp sable on heating to give diimine.
3. A process as claimed in claim 1 or claim 2 in which the aryl sulphonic acid is benzene or p-toluene sulphonic acid.
4. . A process as claimed in claim 1 in which the alkyl sulphonic acid is methane sulphonic acid.
5. A process as claimed in any of claims 1 to in which the sulphonic acid hydrazide is prepared in situ.
6. A process as claimed in any of claims 1 to 5 in which the reduction of thebaine by a sulphonic acid hydrazide is conducted in the presence of a base.
7. A process as claimed in claim 6 in which the base is ammonia, an alkylamine, a substituted alkylamine, an aralkylamine, a substituted aralkylamine or a heterocyclic base.
8. A process as claimed in claim 6 in which the base is an alkali metal hydroxide.
9. A process as claimed in claim 6 in wMch the base is ethanolamine.
10. A process as claimed in claim 6 in which the base is morpholine which also acts as a solvent.
11. A process as claimed in any of claims 1 to 9 which is conducted in the presence of solvent which is not a base,
12. A process as claimed in claim 11 in which the solvent is methyl oxitol or diglyme.
13. A process as claimed in any of claims 1 to 12 in which the ratio of thermally decomposable compound to thebaine is less than or eq al to ¾ : 1.
14. A process as claimed in claim 13 in which the ratio is 2 : 1,
15. A process as claimed in any of claims 1 to 1½ which includes the further step of hydrolysing the 8j ¾-dihydrothebaine to obtain dihydrocodeinone .
16. A process as claimed in any of claims 1 to 15 substantially as herein described with reference to Examples 1 to 7.
17. A process as claimed in any of claims 1 to 15 substantially as herein described with reference to Examples 8 to 10.
18. 8j^L¾-dihydrothebaine when, prepared by a process as claimed in any of claims 1 to lk, 16 or 17.
19. Dihydrocodeinone when prepared by a process as claimed in any of claims 15 to 17.
20. An analgesic composition comprising dihydrocodeinone as claimed in claim 19 together with an inert carrier.
IL38268A 1970-12-11 1971-11-30 Reduction of thebaine to 8,14-dihydrothebaine IL38268A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5892670 1970-12-11

Publications (2)

Publication Number Publication Date
IL38268A0 IL38268A0 (en) 1972-01-27
IL38268A true IL38268A (en) 1974-11-29

Family

ID=10482707

Family Applications (1)

Application Number Title Priority Date Filing Date
IL38268A IL38268A (en) 1970-12-11 1971-11-30 Reduction of thebaine to 8,14-dihydrothebaine

Country Status (17)

Country Link
US (1) US3812132A (en)
JP (1) JPS5511678B1 (en)
AU (1) AU459401B2 (en)
BE (1) BE776304A (en)
CA (1) CA958412A (en)
CH (1) CH556340A (en)
CS (1) CS176251B2 (en)
DE (1) DE2159348A1 (en)
DK (1) DK139974B (en)
FR (1) FR2117924B1 (en)
GB (1) GB1317210A (en)
HU (1) HU164465B (en)
IL (1) IL38268A (en)
NL (1) NL175622C (en)
PL (1) PL81441B1 (en)
SE (1) SE388422B (en)
YU (1) YU39064B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59142770A (en) * 1983-02-02 1984-08-16 Trio Kenwood Corp Driving mechanism of cassette tape recorder
WO2006005112A1 (en) * 2004-07-09 2006-01-19 Tasmanian Alkaloids Pty Ltd Process for the synthesis of hydromorphone
CA2674915C (en) 2006-10-17 2015-06-30 Penick Corporation Process for preparing oxymorphone
EP2073636B1 (en) 2006-10-17 2012-09-05 Penick Corporation Process for preparing oxymorphone
US20080125592A1 (en) * 2006-10-17 2008-05-29 Penick Corporation Process for preparing oxymorphone, naltrexone, and buprenorphine
GB0624880D0 (en) * 2006-12-14 2007-01-24 Johnson Matthey Plc Improved method for making analgesics
US9131649B2 (en) 2008-03-07 2015-09-15 Tasmanian Alkaloids Pty. Ltd Papaver somniferum strain with high concentration of thebaine
US8541647B2 (en) 2008-05-29 2013-09-24 Tasmania Alkaloids Pty, Ltd. Papaver somniferum with high concentration of codeine
PL2480555T3 (en) * 2009-09-22 2016-05-31 SpecGx LLC Methods for producing hydrocodone, hydromorphone or a derivative thereof
AU2011263417B2 (en) 2010-06-11 2014-03-27 Rhodes Technologies Transition metal-catalyzed processes for the preparation of N-allyl compounds and use thereof
EP2580218B1 (en) 2010-06-11 2015-02-25 Rhodes Technologies Process for n-dealkylation of tertiary amines
GB2517000B (en) 2013-08-02 2018-05-09 Johnson Matthey Plc Process for the synthesis of oxymorphone alkaloid and oxymorphone salts
US9273060B2 (en) 2014-03-05 2016-03-01 Johnson Matthey Public Limited Company Processes for making hydrocodone, hydromorphone and their derivatives
WO2015134003A1 (en) 2014-03-05 2015-09-11 Johnson Matthey Public Limited Company Processes for making hydrocodone, hydromorphone and their derivatives
US10155771B2 (en) 2015-11-04 2018-12-18 Noramco, Inc. Selective reduction of morphinan alkaloids

Also Published As

Publication number Publication date
NL7117082A (en) 1972-06-13
SE388422B (en) 1976-10-04
CH556340A (en) 1974-11-29
DK139974B (en) 1979-05-28
JPS5511678B1 (en) 1980-03-26
YU39064B (en) 1984-04-30
US3812132A (en) 1974-05-21
CA958412A (en) 1974-11-26
GB1317210A (en) 1973-05-16
YU308671A (en) 1982-06-30
AU459401B2 (en) 1975-03-27
NL175622C (en) 1984-12-03
HU164465B (en) 1974-02-28
FR2117924A1 (en) 1972-07-28
DK139974C (en) 1979-12-10
NL175622B (en) 1984-07-02
DE2159348A1 (en) 1972-06-15
AU3646971A (en) 1973-06-07
PL81441B1 (en) 1975-08-30
BE776304A (en) 1972-06-06
IL38268A0 (en) 1972-01-27
CS176251B2 (en) 1977-06-30
FR2117924B1 (en) 1975-02-07

Similar Documents

Publication Publication Date Title
IL38268A (en) Reduction of thebaine to 8,14-dihydrothebaine
US2507088A (en) Sulfoxidation process
GB1340911A (en) 3,4-dihydro-1,2,3-oxathiazin-4-one derivatives and a process for their preparation
US3029291A (en) Method for making alkylidenebis
Dubeck et al. CYCLOPENTADIENYL-3-CYCLOPENTENYLNICKEL (II)
US2965655A (en) Process for preparing substituted 1-amino 2, 4-benzene-disulfonamides
US3932510A (en) Process for the preparation of cyclohexanediones-(1,3)
US2321022A (en) Chemical compound and process
JPS598257B2 (en) Method for producing 2-nitro-4,6-dichloro-5-methylphenol
US2484785A (en) 1,4-hydrazino-phthalazine and its acid salts
EP1089976A1 (en) Method of preparing 5- or 8-bromoisoquinoline derivatives
Lieber et al. Infrared spectra of acid azides
Hey et al. 301. Internuclear cyclisation. Part XIII. The decomposition of diazonium salts prepared from N-o-aminobenzoyldiphenylamines. A new molecular rearrangement
US3931210A (en) Production of p-aminobenzoic acid
Hegarty et al. A free-radical analogue of the Chapman rearrangement; conversion of arylhydrazonates into N′ N′-diarylhydrazides
US2917545A (en) Preparation of n-substituted hydrazine derivatives
US3178476A (en) Di-or tri-hydroxybenzyl hydrazides
US3959313A (en) Preparation of dithiolium compounds
US2335273A (en) 3,3-dihalogenoxindoles
US3364215A (en) Nitroso and nitro triazine derivatives
US3278610A (en) Dimerization of naphthols
US1995710A (en) Hydroxyphenylalphaoximinoalkyl ketone and the method of preparing same
US2917512A (en) Preparation of sultams
IL24192A (en) 1-phenylsulfonyl-2-benzimidazolinones and 1-phenylsulfonyl-2-benzimidazolinethiones and process for their preparation
US3117131A (en) Method for producing indoline-6-sulfonamides